ASX - By Stock
|
SPL |
Why no SPL announcement on TGA decison
|
|
joohnno
|
13 |
2.0K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
2.0K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Looks like the fat lady has not yet sung on AZD4320
|
|
joohnno
|
31 |
6.4K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
31
|
6.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Big Pharma or Venture Capitalists
|
|
joohnno
|
19 |
2.5K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
19
|
2.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics
|
|
joohnno
|
148 |
26K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
148
|
26K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Interim decision to amend the Poison Standard for astodrimer sodium
|
|
joohnno
|
32 |
6.9K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
32
|
6.9K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Interim decision to amend the Poison Standard for astodrimer sodium
|
|
joohnno
|
32 |
6.9K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
32
|
6.9K
|
5
|
|
ASX - By Stock
|
SPL |
My pharmacist remains convinced
|
|
joohnno
|
5 |
1.1K |
4 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
5
|
1.1K
|
4
|
|
ASX - By Stock
|
SPL |
A clear sign of TGA drivers
|
|
joohnno
|
17 |
3.4K |
1 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
17
|
3.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Capital raising this Quarter ?
|
|
joohnno
|
15 |
3.4K |
8 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
15
|
3.4K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Capital raising this Quarter ?
|
|
joohnno
|
15 |
3.4K |
3 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
15
|
3.4K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
joohnno
|
40 |
7.5K |
2 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
40
|
7.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Viraleze shows antiviral efficacy in COVID-19 patients
|
|
joohnno
|
74 |
14K |
1 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
74
|
14K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
joohnno
|
37 |
8.0K |
2 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
8.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
joohnno
|
37 |
8.0K |
5 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
8.0K
|
5
|
|
ASX - By Stock
|
SPL |
TGA and medical devices
|
|
joohnno
|
2 |
501 |
0 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
2
|
501
|
0
|
|
ASX - By Stock
|
SPL |
Letter from Cheryl..
|
|
joohnno
|
72 |
16K |
7 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
72
|
16K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Keeping shareholders in the loop
|
|
joohnno
|
46 |
9.5K |
3 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
46
|
9.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Keeping shareholders in the loop
|
|
joohnno
|
46 |
9.5K |
4 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
46
|
9.5K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
New CEO’s focus
|
|
joohnno
|
85 |
19K |
1 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
85
|
19K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
New CEO’s focus
|
|
joohnno
|
85 |
19K |
7 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
85
|
19K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Keeping shareholders in the loop
|
|
joohnno
|
46 |
9.5K |
10 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
46
|
9.5K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
The waiting game and countdown continues
|
|
joohnno
|
36 |
8.7K |
0 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
36
|
8.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
NECTA Dangerous Ideas in Drug Apl
|
|
joohnno
|
5 |
1.3K |
3 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
5
|
1.3K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP docetaxel Phase 2 results
|
|
joohnno
|
131 |
27K |
5 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
131
|
27K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze clinical trial results
|
|
joohnno
|
4 |
1.3K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
History
|
|
joohnno
|
83 |
15K |
1 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
83
|
15K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
3603 days
|
|
joohnno
|
5 |
1.3K |
2 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
5
|
1.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AGM Chairman's address and CEO presentation
|
|
joohnno
|
27 |
7.7K |
9 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
27
|
7.7K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AGM Chairman's address and CEO presentation
|
|
joohnno
|
27 |
7.7K |
4 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
27
|
7.7K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AGM Results
|
|
joohnno
|
9 |
2.5K |
3 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
9
|
2.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AGM Results
|
|
joohnno
|
9 |
2.5K |
3 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
9
|
2.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Could we pleasantly be surprised at AGM
|
|
joohnno
|
34 |
7.3K |
3 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
34
|
7.3K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Tomorrow's AGM
|
|
joohnno
|
15 |
2.9K |
5 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
15
|
2.9K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Shareholder Update
|
|
joohnno
|
24 |
4.6K |
3 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
24
|
4.6K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
ADVERTISING
|
|
joohnno
|
16 |
3.3K |
2 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
16
|
3.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Submitted questions with notice for AGM
|
|
joohnno
|
6 |
1.5K |
4 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
6
|
1.5K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
joohnno
|
91 |
23K |
2 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
91
|
23K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma announces new CEO, Ms Cheryl Maley
|
|
joohnno
|
91 |
23K |
15 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
91
|
23K
|
15
|
|
ASX - By Stock
|
SPL |
Re:
Sale of DEP platform?
|
|
joohnno
|
25 |
5.1K |
3 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
25
|
5.1K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notification regarding unquoted securities - SPL
|
|
joohnno
|
23 |
5.7K |
9 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
23
|
5.7K
|
9
|
|
ASX - By Stock
|
SPL |
Re:
Expectations for November
|
|
joohnno
|
3 |
931 |
2 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
3
|
931
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE Nasal Spray Approved in Malaysia
|
|
joohnno
|
33 |
8.5K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
33
|
8.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
joohnno
|
32 |
7.4K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
32
|
7.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
joohnno
|
36 |
8.4K |
7 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
36
|
8.4K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Who are buying the 50 million shares
|
|
joohnno
|
29 |
7.7K |
2 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
29
|
7.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Who are buying the 50 million shares
|
|
joohnno
|
29 |
7.7K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
29
|
7.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Who are buying the 50 million shares
|
|
joohnno
|
29 |
7.7K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
29
|
7.7K
|
1
|
|
ASX - By Stock
|
ATP |
Pearls for men
|
|
joohnno
|
3 |
606 |
0 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
3
|
606
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP Cabazitaxel Phase 2 Results in Multiple Cancer
|
|
joohnno
|
73 |
18K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
73
|
18K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP irinotecan clinical data presented at AACR meeting
|
|
joohnno
|
25 |
5.7K |
3 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
25
|
5.7K
|
3
|
|